Gaurav Sharma

Chief Operating Officer

As the Chief Operating Officer, Gaurav is responsible for leading our development operations group (DevOps), consisting of strategic feasibility, study start up, project and clinical management, clinical monitoring, clinical development, and site management services including TMF group. He brings a rich background from both the biopharmaceutical and CRO perspective, as his previous experience includes leading Clinical Operations at Deciphera Pharmaceuticals, where he was operational asset lead for Rebastinib and ULK Inhibitor, as well as serving as SVP and Therapeutic Area Leader of Oncology & Hematology at Worldwide Clinical Trials where he focused on advanced therapies like cell and gene therapy. In addition, he held roles of progressive responsibility in project management starting at ICON Plc and then at Premier Research, where he served as SVP and Head of Global Project Management.

Gaurav holds a Master’s degree in Pharmacology from JSS College of Pharmacy.

Leading a new way

The latest from Caidya

Explore our news and updates as we liberate the clinical research process.

17th Annual Outsourcing in Clinical Trials West Coast 2025

11th February 2025 to 12th February 2025
Hyatt Regency San Francisco Airport, Burlingame, CA, USA

01/28/2025

Caidya Names Brandon Pallott as CCO to Drive Innovative Commercial Initiatives and Market Expansion

RALEIGH, N.C.; Jan. 28, 2025 – Caidya, a leading global,...

01/13/2025

Caidya Announces $165 Million Strategic Growth Investment from Rubicon Founders

RALEIGH, N.C.; Jan. 13, 2025 – Caidya, a leading global...
Skip to toolbar